PSNL: Pangali rega marang bathi tumrap wutah personalis.com
Personalis, Inc. (PSNL) is optimizing its contractor workflows by expanding its partner network to ensure the seamless execution of oncology tests. The growth-adjusted P/E on GURU.Markets reflects this progress, with the value stabilizing at 0.00. The company's revenue is based on genomic sequencing for pharma behemoths, while premium pricing is sustained by the exceptional data accuracy of precision medicine.
Rincian metrik lan analitis perusahaan Personalis, Inc. (PSNL)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Personalis, Inc.|PSNL - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas personalis.com|PSNL - Gunggung utang perusahaan|Utang-utang marang nilai buku Personalis Corp|PSNL - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Personalis|Koefisien jangkoan perantara personalis.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
PSNL - Bathi resik perusahaan|Bathi resik sing dikarepake Personalis, Inc.|PSNL - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Personalis Genomics|PSNL - Pangali PEG|Pangali EV/EBITDA Personalis Corp|PSNL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Personalis|PSNL - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan personalis.com|PSNL - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Personalis, Inc.
Analisis umum perusahaan:PSNL - Personalis Inc
The high scientific potential of Personalis, Inc. (PSNL) in AI diagnostics and liquid biopsy necessitates a correlation between share price and earnings dynamics. The history of P/E to growth rate ratios allows for an assessment of whether the market capitalization justifies the speed of business expansion: a ratio below one signals that the asset is undervalued relative to its prospects, highlighting potentially fast-growing stocks provided that debt load remains controlled.
Pesaing Personalis, Inc.
ONC (BeiGene Ltd.) - Koefisien bali modal nimbang wutah|Pangali PEG HALO (Halozyme Inc.)|RVMD - Pangali rega marang bathi tumrap wutah|AAPG: Pangali rega marang bathi tumrap wutah|CGON - Pangali PEG|UroGen Pharma (URGN) - Rasio rega marang bathi tumrap wutah|Bicara Therapeutics Inc - Koefisien bali modal nimbang wutah|ERAS (Erasca Corp) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Delcath Corp DCTH|Rasio rega marang bathi tumrap wutah Y-mAbs Therapeutics (YMAB)|AURA: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG CADL (Candel Therapeutics, Inc.)|Accuray Inc (ARAY) - Rega marang bathi kanthi panyesuaian wutah|SLS - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ACTU (Actuate Therapeutics Inc)|Citius Oncology, Inc. (CTOR) - Rasio rega marang bathi tumrap wutah|HURA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Protara Therapeutics, Inc.|Rega marang bathi kanthi panyesuaian wutah Fate Therapeutics Inc FATE|Rasio rega marang bathi tumrap wutah Aadi Bioscience Inc (WHWK)|tscan.com - Rasio P/E diaturake wutah|Pangali PEG CSBR (Champions Oncology, Inc.)|Pangali PEG XBiotech Inc XBIT|CVM - Rasio rega marang bathi tumrap wutah|OSTX: Rasio rega marang bathi tumrap wutah|RADX: Pangali PEG|ARTV - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Adlai Nortye Ltd|verupharma.com (VERU) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah TPST (Tempest Therapeutics, Inc.)|XLO (xiliotx.com) - Koefisien bali modal nimbang wutah|Pangali PEG RENB (Renovaro)|Kapitalisasi marang bathi resik kanthi nimbang wutah Mural Oncology PLC (MURA)|KAPA - Rasio rega marang bathi tumrap wutah|OKUR (OnKure Therapeutics Inc) - Rasio P/E diaturake wutah|GDTC: Pangali PEG|Pangali rega marang bathi tumrap wutah Curis|Pangali rega marang bathi tumrap wutah APLM|Tharimmune Corporation (THAR) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Advanced Biomed Inc (ADVB)|GNPX: Rasio kapitalisasi marang bathi lan wutah|Rasio rega marang bathi tumrap wutah Calidi Biotherapeutics, Inc. CLDI|Kapitalisasi marang bathi resik kanthi nimbang wutah Sunshine Biopharma Inc. (SBFM)|XBIO - Rasio rega marang bathi tumrap wutah|SLRX (Salarius Pharma) - Rasio P/E diaturake wutah|Purple Biotech (PPBT) - Rasio rega marang bathi tumrap wutah|AONC (American Oncology Network, Inc.) - Rasio rega marang bathi tumrap wutah|BGNE (BeiGene) - Pangali PEG|Pangali rega marang bathi tumrap wutah Checkpoint Therapeutics Inc. (CKPT)|Pangali PEG ELEV|Pangali PEG icadmed.com (ICAD)|Rasio rega marang bathi tumrap wutah Ikena Oncology IKNA|NTBL: Rasio P/E diaturake wutah|Viracta - Pangali PEG|MorphoSys Inc (MOR) - Pangali rega marang bathi tumrap wutah|NAYA: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Ascentage (AAPGV)
